New Journal Coming Soon
touchREVIEWS in Infectious Diseases
Share
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Select a Section…
1
Article
Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
It is my pleasure to introduce this issue of touchREVIEWS in Infectious Diseases for 2025, which features a diverse range of reviews and editorials addressing the scientific, clinical and policy dimensions of infectious disease management in a rapidly evolving global landscape. Access the latest issue here This issue opens with an editorial by Joshua Craft […]
Mark CompleteCompleted
BookmarkBookmarked
It is my pleasure to introduce this issue of touchREVIEWS in Infectious Diseases for 2025, which features a diverse range of reviews and editorials addressing the scientific, clinical and policy dimensions of infectious disease management in a rapidly evolving global landscape. ...
Mark CompleteCompleted
BookmarkBookmarked
This article provides an overview of nirmatrelvir/ritonavir (Paxlovid®; Pfizer, New York, NY, USA), an oral antiviral agent manufactured by Pfizer, used for treating mild-to-moderate coronavirus disease 2019 (COVID-19). Herein, we summarize the drug’s pharmacology, including its mechanism of action ...
Mark CompleteCompleted
BookmarkBookmarked
A double-stranded DNA virus of the Orthopoxvirus family, mpox (formerly monkeypox), continues to infect people daily, following the 2022 global outbreak.1 Two clades (clade 1 and clade 2) have been identified, with the 2022 outbreak caused by a subclade of clade 2, referred to as ...
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
